Evolve Healthcare Partners

Overview

Evolve Healthcare Partners is a mid-market private equity firm specializing in European healthcare investments. The firm focuses on partnering with mid-sized healthcare companies across various segments, excluding biotech, aiming to enhance their growth and strategic positioning through both organic initiatives and mergers and acquisitions. Their operationally focused and hands-on approach is designed to improve the growth profiles of healthcare companies, generating above-industry-average returns for investors in a sector that continues to evolve and inspire. Evolve Healthcare Partners seeks to invest in European healthcare companies with revenues up to €200 million and EBITDAs up to €50 million. Their typical equity investments range from €20 million to €50 million, with flexibility to secure larger equity needs through co-investors. The firm emphasizes the quality of management teams and assets, offering flexible financial structures tailored to specific opportunities, including 100% acquisitions, majorities, and minorities. Their partnering approach differentiates them, as they collaboratively design optimal financial structures with shareholders and management teams. The firm's founding team comprises former international C-level healthcare executives and investors, bringing a strong operational track record to their investment strategy. Their capabilities in corporate strategy and development, commercial operations, and innovation strategy enable them to act on key value creation levers that can change the growth profile of the companies they partner with. By doing so, they aim to ensure the long-term sustainability of these companies, having a social impact on sustainable healthcare. Their international network of partners and contacts further facilitates growth and operational efficiencies, aligning with partners through balanced shareholder agreements and board representation to guarantee alignment of interests from day one.

Investment Focus

• Mid-sized European healthcare companies with revenues up to €200 million and EBITDAs up to €50 million

Portfolio Companies